Amicus Therapeutics Filing Becomes Effective

Ticker: FOLD · Form: EFFECT · Filed: Apr 30, 2026 · CIK: 0001178879

Amicus Therapeutics, Inc. EFFECT Filing Summary
FieldDetail
CompanyAmicus Therapeutics, Inc. (FOLD)
Form TypeEFFECT
Filed DateApr 30, 2026
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: filing-effectiveness, sec-filing, regulatory

TL;DR

Amicus Therapeutics filing effective 4/29/26, SEC accepted 4/30/26.

AI Summary

Amicus Therapeutics, Inc. filed an EFFECT form on April 30, 2026, indicating the effectiveness of a filing related to their securities. The filing, with accession number 9999999995-26-001363, was accepted at 00:15:02. The effectiveness date for the filing was April 29, 2026.

Why It Matters

This filing signifies that a previously submitted document related to Amicus Therapeutics' securities has met SEC requirements and is now officially effective, which can be a precursor to significant corporate actions.

Risk Assessment

Risk Level: low — An EFFECT filing itself is a procedural notification and does not inherently carry financial risk.

Key Numbers

  • 2026-04-29 — Effectiveness Date (The date the filing officially became active.)
  • 2026-04-30 — Acceptance Date (The date the SEC processed and accepted the filing.)

Key Players & Entities

  • AMICUS THERAPEUTICS, INC. (company) — Filer
  • 9999999995-26-001363 (dollar_amount) — SEC Accession Number
  • 2026-04-30 (dollar_amount) — Acceptance Date
  • 2026-04-29 (dollar_amount) — Effectiveness Date
  • 0001178879 (dollar_amount) — CIK Number

FAQ

What type of filing is an 'EFFECT' form?

An 'EFFECT' form, as indicated in the filing for Amicus Therapeutics, Inc., signifies a Notice of Effectiveness, meaning a previously submitted document has met SEC requirements and is now officially effective.

What is the SEC Accession Number for this filing?

The SEC Accession Number for this filing is 9999999995-26-001363.

When was this filing accepted by the SEC?

This filing was accepted by the SEC on 2026-04-30 at 00:15:02.

What is the CIK number for Amicus Therapeutics, Inc.?

The CIK number for Amicus Therapeutics, Inc. is 0001178879.

What is the business address and phone number for Amicus Therapeutics, Inc.?

The business address for Amicus Therapeutics, Inc. is 47 HULFISH STREET PRINCETON NJ 08542, and their phone number is (609) 662-2000.

Filing Details

This Form EFFECT (Form EFFECT) was filed with the SEC on April 30, 2026 regarding AMICUS THERAPEUTICS, INC. (FOLD).

View full filing on EDGAR

View Full Filing

View this EFFECT filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.